CorMedix Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +11.0% | +6.7% | +47.0% | +30.5% | -34.1% | -15.5% | -20.2% | -65.7% | -100.0% | – | +617.0% | |
| – | -28.5% | +15.0% | -68.6% | +245.1% | -5.9% | -45.1% | -27.3% | -97.5% | +5,405.1% | +1,452.1% | +1,027.1% | |
| – | – | – | – | -84.6% | -372.5% | – | +22.1% | +46.8% | -433.3% | – | +584.6% | |
| – | +376.4% | +150.5% | +55.6% | -23.1% | -41.3% | +21.0% | -1.8% | -18.7% | +23.2% | -70.0% | +390.4% | |
| – | +40.1% | -13.5% | -2.6% | -6.7% | +22.2% | +40.7% | +17.8% | +22.4% | -11.6% | +69.4% | +127.7% | |
| – | +91.4% | +48.8% | +34.6% | -18.8% | -22.2% | +30.3% | +8.2% | +4.1% | +58.9% | +28.5% | +100.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +89.9% | -66.9% | +328.6% | -66.7% | +41,944.2% | -95.8% | -52.0% | +66.3% | +29.3% | +6.1% | +7,541.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +89.9% | -66.9% | -2,485.0% | – | +13,788.4% | -202.1% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.